From: Asian Americans & chronic kidney disease in a nationally representative cohort
 |  | Race | |
---|---|---|---|
Outcome | Statistic | Asians | White |
ACR mg/g (A1, A2, A3) | Mean ± SE | 38.4 ± 7.1 | 25.7 ± 2.6 |
[CKD Stage 1–5] | Median (Q1, Q3) | 7.2 (4.8, 12.8) | 6.8 (4.6, 12.1) |
ACR ≥ 30 mg/g (A2) | Mean ± SE | 311.4 ± 68.1 | 201.4 ± 27.0 |
[CKD Stage 3] | Median (Q1, Q3) | 76.6 (39.8, 198.1) | 57.4 (39.6, 120.8) |
ACR > 300 mg/g (A3) | Mean ± SE | 1255.7 ± 298 | 1225.1 ± 204 |
[CKD Stages 4–5] | Median (Q1, Q3) | 628.2 (427.0, 1081.6) | 657.1 (404.9, 1140.9) |
eGFR ml/min/1.73 m2 (G1 to G5) | Mean ± SE | 101.2 ± 0.5 | 90.3 ± 0.3 |
[CKD Stages 1–5] | Median (Q1,Q3) | 103.3 (90.2, 115.5) | 91.8 (76.8, 105.5) |
eGFR < 60 ml/min/1.73 m2 (G3a-G5) | Mean ± SE | 48.6 ± 1.63 | 47.7 ± 0.57 |
[CKD Stage 3 to 5] | Median (Q1, Q3) | 51.8 (43.9, 57.5) | 50.7 (41.9, 55.7) |
eGFR < 45 ml/min/1.73 m2 (G3b-G5) | Mean ± SE | 34.1 ± 2.8 | 33.5 ± 0.9 |
[CKD Stage 3 to 5] | Median (Q1, Q3) | 37.1 (27.9, 42.6) | 35.7 (30.6, 41.0) |